source
- #ASGCT26 dispatch: In vivo CAR-T is everywhereBOSTON — Greetings from Boston, where I’ve been on the ground covering the American Society of Gene & Cell Therapy’s annual meeting all week. It’s a crucial moment for the field. Genetic medicine d…Endpoints · 3mo ago↗ source
- Create Medicines raises $122M to bolster in vivo CAR-T therapiesThe fresh funds will support the biotech's pipeline of RNA-based CAR-T cell therapies for cancer and autoimmune conditions.BioPharma Dive · 3mo ago↗ source
- Drugmakers have to go through rigorous tests to get a lower tariff rateLanding a reduced 20% tariff rate will require pharma companies to fill out extensive paperwork and be closely monitored by the Department of Commerce. President Donald Trump signed an executive or…Endpoints